Papers
2
Total Citations
13
H-Index
2
About
Dr. Stefania Volpe is a leading clinical researcher in head and neck oncology, with a specialized focus on the multidisciplinary management of oropharyngeal cancer, particularly HPV-positive disease. Her major contributions lie in generating real-world evidence that directly compares modern surgical and non-surgical treatment paradigms. In her highly cited 2022 study, she provided critical data on oncologic and functional outcomes by comparing upfront transoral robotic surgery (TORS) against intensity-modulated radiation therapy (IMRT) for advanced HPV-positive oropharyngeal cancer, a work that has garnered 9 citations for its practical clinical insights. Dr. Volpe has also advanced the understanding of treatment-related toxicity, notably quantifying the incidence of soft tissue necrosis in patients receiving postoperative radiotherapy after TORS. Her preliminary 2020 findings on this topic, cited 4 times, are essential for refining adjuvant treatment protocols and improving patient quality of life. By bridging the gap between surgical innovation and radiation oncology, Dr. Volpe’s research directly informs therapeutic decision-making at tertiary comprehensive cancer centers, establishing her as a key voice in optimizing outcomes for head and neck cancer patients.
Research Focus
Key Achievements
Top Papers
- 1
- 2